154 related articles for article (PubMed ID: 35107507)
1. Pharmaceutical patent term extension and patent prosecution in Brazil (1997-2018).
Mercadante E; Paranhos J
Cad Saude Publica; 2022; 38(1):e00043021. PubMed ID: 35107507
[TBL] [Abstract][Full Text] [Related]
2. Should ANVISA be permitted to reject pharmaceutical patent applications in Brazil?
Mueller LL; Taketsuma Costa SM
Expert Opin Ther Pat; 2014 Jan; 24(1):1-4. PubMed ID: 24206261
[TBL] [Abstract][Full Text] [Related]
3. Reaching a milestone in pharmaceutical patenting in Brazil.
Blasi GD
Pharm Pat Anal; 2018 Nov; 7(6):229-233. PubMed ID: 30632452
[No Abstract] [Full Text] [Related]
4. [How much does the backlog on drug patents cost for health in Brazil?].
Jannuzzi AHL; Vasconcellos AG
Cad Saude Publica; 2017 Aug; 33(8):e00206516. PubMed ID: 28832788
[TBL] [Abstract][Full Text] [Related]
5. The consequences of 'double examination' for pharmaceutical patent applications in Brazil.
Salerno G
Pharm Pat Anal; 2017 Mar; 6(2):49-51. PubMed ID: 28274178
[No Abstract] [Full Text] [Related]
6. Expedited pharma patenting in Brazil.
Moreira P
Pharm Pat Anal; 2019 Mar; 8(2):51-59. PubMed ID: 30887881
[TBL] [Abstract][Full Text] [Related]
7. Enabling policy planning and innovation management through patent information and co-authorship network analyses: a study of tuberculosis in Brazil.
Vasconcellos AG; Morel CM
PLoS One; 2012; 7(10):e45569. PubMed ID: 23056208
[TBL] [Abstract][Full Text] [Related]
8. [Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property].
Jannuzzi AH; Vasconcellos AG; de Souza CG
Cad Saude Publica; 2008 Jun; 24(6):1205-18. PubMed ID: 18545747
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Brazilian biotechnology patent activity from 1975 to 2010.
Dias F; Delfim F; Drummond I; Carmo AO; Barroca TM; Horta CC; Kalapothakis E
Recent Pat DNA Gene Seq; 2012 Aug; 6(2):145-59. PubMed ID: 22670606
[TBL] [Abstract][Full Text] [Related]
10. Patenting pharmaceuticals in China.
Han W; Luo J
Pharm Pat Anal; 2016 Jul; 5(4):249-59. PubMed ID: 27338759
[TBL] [Abstract][Full Text] [Related]
11. Patenting trends by Mexican pharmaceutical companies.
Villafaña-Diaz L; Perez-Garcia JC; Barron-Villaverde D; Perez-Santos M
Pharm Pat Anal; 2023 Nov; 12(6):275-286. PubMed ID: 38197381
[No Abstract] [Full Text] [Related]
12. Update on Brazil's pharma patent landscape.
Gosain R
Pharm Pat Anal; 2016 Sep; 5(6):385-390. PubMed ID: 27804784
[TBL] [Abstract][Full Text] [Related]
13. Patent term extensions: issues, challenges and implications for pharmaceuticals.
Clark L; Beadle D
Pharm Pat Anal; 2012 Sep; 1(4):427-35. PubMed ID: 24236881
[TBL] [Abstract][Full Text] [Related]
14. [The cost to the Brazilian Unified National Health System of the extension of drug patent terms].
Paranhos J; Mercadante E; Hasenclever L
Cad Saude Publica; 2020; 36(11):e00169719. PubMed ID: 33331592
[TBL] [Abstract][Full Text] [Related]
15. Nonobviousness of pharmaceutical inventions: implications for patent prosecution and litigation.
Dhulap S; Kulkarni M
Pharm Pat Anal; 2019 Jul; 8(4):91-107. PubMed ID: 31414965
[TBL] [Abstract][Full Text] [Related]
16. [Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].
Chaves GC; Oliveira MA; Hasenclever L; de Melo LM
Cad Saude Publica; 2007 Feb; 23(2):257-67. PubMed ID: 17221075
[TBL] [Abstract][Full Text] [Related]
17. Research on the pharmaceutical intellectual property protection and supervision of pharmacy administration.
Xu Z; Chen W
Pak J Pharm Sci; 2017 May; 30(3(Special)):1081-1087. PubMed ID: 28671085
[TBL] [Abstract][Full Text] [Related]
18. Nanotechnology and Protection of Intellectual Property: Emerging Trends.
Siri JGS; Fernando CAN; De Silva SNT
Recent Pat Nanotechnol; 2020; 14(4):307-327. PubMed ID: 32532198
[TBL] [Abstract][Full Text] [Related]
19. What do patents tell us about microalgae in agriculture?
Murata MM; Ito Morioka LR; Da Silva Marques JB; Bosso A; Suguimoto HH
AMB Express; 2021 Nov; 11(1):154. PubMed ID: 34816320
[TBL] [Abstract][Full Text] [Related]
20. The political contradictions of incremental innovation: lessons from pharmaceutical patent examination in Brazil.
Shadlen KC
Polit Soc; 2011; 39(2):143-74. PubMed ID: 21913365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
